Value & Access Advisory
Organisations make a series of evidence, value, access and pricing decisions throughout the lifecycle of a health technology.
Powered by Lightning Insights and our guiding framework, Explore • Build • Optimise framework, we help organisations generate evidence, demonstrate value and support patient access across global healthcare markets.
How do you generate value and support patient access?
Demonstrating value requires a clear understanding of stakeholder expectations, evidence requirements and market-specific access considerations.
Whether supporting early evidence planning, reimbursement strategy, value communication or pricing decisions, organisations need access to the right expertise and insight at the right time.
Understanding what matters most to decision-makers can help shape evidence, strengthen value propositions and support patient access.
Specialist expertise across the product lifecycle
We combine specialist expertise with stakeholder insight to help organisations understand evidence requirements, demonstrate value and support access and pricing objectives throughout the product lifecycle.
Value, access & pricing strategy
Build evidence-based strategies that support value recognition and patient access
Develop integrated value, access and pricing strategies aligned to stakeholder needs, evidence requirements and commercial objectives.
Stakeholder and market insights
Strengthen decisions through stakeholder insight
Powered by Lightning Insights, we engage payers, clinicians and healthcare decision-makers to validate assumptions, identify opportunities and inform strategy.
Flexible advisory support
Access expertise when and where it's needed
Provide specialist support across value, access and pricing activities, tailored to the needs of each asset, team and stage of development.
What drives successful value, access and pricing outcomes?
Explore some of the questions organisations commonly face when navigating evidence generation, value demonstration, pricing and patient access.
Evidence requirements can vary between payers, HTA bodies, healthcare professionals and procurement stakeholders. Understanding which clinical, economic and real-world evidence requirements are most likely to influence decisions can help organisations prioritise evidence generation and reduce future access risks.
Demonstrating value often requires more than clinical evidence alone. Cost-effectiveness, budget impact, patient outcomes, real-world evidence and implementation considerations may all influence value perception across different stakeholders and markets.
Evidence gaps, stakeholder expectations, pricing decisions, reimbursement requirements, HTA processes and evolving policy environments can all influence value, access and pricing outcomes. Understanding these factors early can help organisations make more informed strategic decisions and reduce future risks.
Value and access pathways, reimbursement processes and evidence expectations differ across countries and healthcare systems. Understanding these differences can help organisations develop strategies that address both global and local requirements.
Understanding stakeholder expectations has always been central to effective value, access and pricing strategy. Advances in data, analytics and AI are creating new ways to identify patterns, assess evidence and explore strategic scenarios. When combined with stakeholder insight and value and access expertise, these capabilities can support more informed and confident decision-making.
Turning insight into action
Our guiding framework, Explore • Build • Optimise, provides a flexible approach to helping organisations generate evidence, demonstrate value and support patient access. Powered by Lightning Insights, it combines stakeholder perspectives with expertise across market assessment, evidence generation, health economics, pricing, reimbursement and value communication.
Explore
Understand opportunities and priorities through: unmet need assessment, market analysis, indication prioritisation and evaluation of the clinical and economic drivers of value.
Build
Develop evidence and value strategies through disease burden assessment, clinical evidence planning, health economic strategy development and real-world evidence generation.
Optimise
Strengthen value, access and pricing outcomes through pricing strategy, payer assessment, access pathway planning, value message development and stakeholder communications.
Looking for flexible advisory support?
Whether you're refining strategy, generating evidence, validating assumptions or preparing for stakeholder engagement, we're here to help.
Value and access case studies
Explore how we've supported clients in generating evidence, demonstrating value and supporting patient access across global markets.
European pricing & access for an orphan haematology disorder
GVD, value toolkit and economic model development for a new therapy for acromegaly
China access pathway and commercial opportunity assessment to inform launch prioritisation
International market profiling and prioritisation analysis for a new therapy for a rare neurological disorder
Global pricing governance programme and resources for a biotech company
